Pages that link to "Q38719607"
Jump to navigation
Jump to search
The following pages link to Prostate Cancer: PI-RADS Version 2 Helps Preoperatively Predict Clinically Significant Cancers (Q38719607):
Displaying 42 items.
- Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: Prostate Imaging Reporting and Data System Version 1 versus Version 2. (Q31137158) (← links)
- Diagnostic value and relative weight of sequence-specific magnetic resonance features in characterizing clinically significant prostate cancers (Q33783620) (← links)
- An initial negative round of targeted biopsies in men with highly suspicious multiparametric magnetic resonance findings does not exclude clinically significant prostate cancer-Preliminary experience (Q36219426) (← links)
- Developing a nomogram based on multiparametric magnetic resonance imaging for forecasting high-grade prostate cancer to reduce unnecessary biopsies within the prostate-specific antigen gray zone (Q36265470) (← links)
- The combination of prostate imaging reporting and data system version 2 (PI-RADS v2) and periprostatic fat thickness on multi-parametric MRI to predict the presence of prostate cancer (Q36364446) (← links)
- PI-RADS version 2: Evaluation of diffusion-weighted imaging interpretation between B = 1000 and B = 1500 s/mm(2). (Q38613875) (← links)
- A meta-analysis of use of Prostate Imaging Reporting and Data System Version 2 (PI-RADS V2) with multiparametric MR imaging for the detection of prostate cancer (Q38705859) (← links)
- Prostate zonal anatomy correlates with the detection of prostate cancer on multiparametric magnetic resonance imaging/ultrasound fusion-targeted biopsy in patients with a solitary PI-RADS v2-scored lesion (Q38787731) (← links)
- A urologist's perspective on prostate cancer imaging: past, present, and future (Q38823661) (← links)
- Detection of Clinically Significant Prostate Cancer: Short Dual-Pulse Sequence versus Standard Multiparametric MR Imaging-A Multireader Study. (Q38874202) (← links)
- PI-RADS version 2: quantitative analysis aids reliable interpretation of diffusion-weighted imaging for prostate cancer. (Q39106378) (← links)
- Magnetic Resonance Imaging Provides Added Value to the Prostate Cancer Prevention Trial Risk Calculator for Patients With Estimated Risk of High-grade Prostate Cancer Less Than or Equal to 10. (Q39129035) (← links)
- Role of PI-RADSv2 with multiparametric MRI in determining who needs active surveillance or definitive treatment according to PRIAS. (Q39247844) (← links)
- Incorporating Oxygen-Enhanced MRI into Multi-Parametric Assessment of Human Prostate Cancer (Q41664708) (← links)
- A Promising Future for Prostate Cancer Diagnostics (Q42370036) (← links)
- Validation of Prostate Imaging-Reporting and Data System Version 2: A Retrospective Analysis. (Q47616425) (← links)
- A novel biopsy-related parameter derived from location and relationship of positive cores on standard 12-core trans-rectal ultrasound-guided prostate biopsy: a useful parameter for predicting tumor volume compared to number of positive cores (Q47757923) (← links)
- Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Identify Clear Cell Renal Cell Carcinoma in cT1a Renal Masses. (Q47866161) (← links)
- Significant changes of T2 value in the peripheral zone and seminal vesicles after ejaculation (Q48230102) (← links)
- Prostate Imaging-Reporting and Data System Version 2: Beyond Prostate Cancer Detection. (Q52665654) (← links)
- Multiparametric MR imaging of peripheral zone prostate cancer: effect of postbiopsy hemorrhage on cancer detection according to Gleason score and tumour volume. (Q53081178) (← links)
- Negative Multiparametric Magnetic Resonance Imaging of the Prostate Predicts Absence of Clinically Significant Prostate Cancer on 12-Core Template Prostate Biopsy. (Q53417273) (← links)
- PI-RADS v2: Current standing and future outlook. (Q55522517) (← links)
- A prospective accuracy study of Prostate Imaging Reporting and Data System version 2 on multiparametric magnetic resonance imaging in detecting clinically significant prostate cancer with whole-mount pathology (Q57067824) (← links)
- Impact of multiparametric MRI and MRI-targeted biopsy on pre-therapeutic risk assessment in prostate cancer patients candidate for radical prostatectomy (Q57111662) (← links)
- Establishing a prediction model for prostate cancer bone metastasis (Q60922793) (← links)
- Predictive role of PI-RADSv2 and ADC parameters in differentiating Gleason pattern 3 4 and 4 3 prostate cancer (Q61451878) (← links)
- A calculator based on prostate imaging reporting and data system version 2 (PI-RADS V2) is a promising prostate cancer predictor (Q64069330) (← links)
- A new predictor is comparable to the updated nomogram in predicting the intermediate- and high-risk prostate cancer but outperforms nomogram in reducing the overtreatment for the low-risk Pca (Q64077978) (← links)
- Diagnostic Accuracy of a MR Protocol Acquired with and without Endorectal Coil for Detection of Prostate Cancer: A Multicenter Study (Q64113934) (← links)
- Accuracy of preoperative multiparametric magnetic resonance imaging for prediction of unfavorable pathology in patients with localized prostate cancer undergoing radical prostatectomy (Q88548776) (← links)
- Diagnostic Performance and Interobserver Consistency of the Prostate Imaging Reporting and Data System Version 2: A Study on Six Prostate Radiologists with Different Experiences from Half a Year to 17 Years (Q89586387) (← links)
- New Biopsy Techniques and Imaging Features of Transrectal Ultrasound for Targeting PI-RADS 4 and 5 Lesions (Q89783216) (← links)
- Intra- and interreader reproducibility of PI-RADSv2: A multireader study (Q90690736) (← links)
- Impact of PI-RADS v2 on indication of prostate biopsy (Q91640783) (← links)
- A novel nomogram combined PIRADS v2 and neutrophil-to-lymphocyte ratio to predict the risk of clinically significant prostate cancer in men with PSA < 10 ng/ml at first biopsy (Q92214704) (← links)
- Low PI-RADS assessment category excludes extraprostatic extension (≥pT3a) of prostate cancer: a histology-validated study including 301 operated patients (Q92466085) (← links)
- Combining Prostate-Specific Antigen Parameters With Prostate Imaging Reporting and Data System Score Version 2.0 to Improve Its Diagnostic Accuracy (Q92540089) (← links)
- A review of optimal prostate biopsy: indications and techniques (Q93134999) (← links)
- The prediction value of PI-RADS v2 score in high-grade Prostate Cancer: a multicenter retrospective study (Q97093995) (← links)
- Prediction of pathologic upgrading in Gleason score 3 4 prostate cancer: Who is a candidate for active surveillance? (Q97527417) (← links)
- Risk Factors for Pathologically Confirmed Lymph Nodes Metastasis in Patients With Clinical T2N0M0 Stage Prostate Cancer (Q99406948) (← links)